Northern Trust’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.5M | Sell |
264,188
-50,290
| -16% | -$2.18M | ﹤0.01% | 1988 |
|
|
2025
Q1 | $11.7M | Sell |
314,478
-12,814
| -4% | -$479K | ﹤0.01% | 1942 |
|
|
2024
Q4 | $14.8M | Buy |
327,292
+20,743
| +7% | +$940K | ﹤0.01% | 1888 |
|
|
2024
Q3 | $18M | Sell |
306,549
-4,654
| -1% | -$273K | ﹤0.01% | 1683 |
|
|
2024
Q2 | $12.2M | Sell |
311,203
-13,021
| -4% | -$512K | ﹤0.01% | 1877 |
|
|
2024
Q1 | $21.5M | Buy |
324,224
+147,451
| +83% | +$9.8M | ﹤0.01% | 1544 |
|
|
2023
Q4 | $4.94M | Buy |
176,773
+15,635
| +10% | +$437K | ﹤0.01% | 2529 |
|
|
2023
Q3 | $3.43M | Buy |
+161,138
| New | +$3.43M | ﹤0.01% | 2657 |
|